ACAmy Peterson Case

Amy Peterson Case

*This is an algorithmically generated author record based on publicly available information.

Amy Peterson Case has a total of 9 co-authors. Here are the top co-authors by number of shared publications:

  • Cara T. Mai

    National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, USA

    1 shared publication
  • Joe Mulinare

    National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, Georgia

    1 shared publication
  • Judy Major

    North Carolina Birth Defect Monitoring Program, Fullerton Genetics at Mission Hospitals, Asheville, North Carolina

    1 shared publication
  • Julianne S. Collins

    Department of Genetics and Biochemistry, Clemson University, 100 Jordan Hall, Clemson, South Carolina 29634-0318, USA

    1 shared publication
  • Kay Pearson

    Oklahoma Birth Defects Registry, Oklahoma State Department of Health, Oklahoma City, Oklahoma

    1 shared publication
  • Mark A. Canfield

    Birth Defects Epidemiology and Surveillance Branch Texas Department of State Health Services Austin Texas USA

    1 shared publication

Latest Publications

  • Using State Birth Defects Registries to Evaluate Regional Critical Congenital Heart Disease Newborn Screening

    by Amy Peterson Case, Stephanie D. Miller, Monica R. McClain

    Background: Most states have now passed legislation mandating pulse oximetry for all newborns, or have promulgated regulations or guidelines to encourage use of routine pulse oximetry. State‐based birth defects registries may be well positioned to track and evaluate critical congenital heart disease (CCHD) screening coverage and outcomes. This purpose of this study was to determine: (1) the proportion of cases detected by screening, (2) health services use by children with CCHDs during the first year of life, and (3) mortality outcomes.Methods: Records of children born in 2012 to 2013 with any of seven CCHD lesions were identified in New England birth defects databases. Information was abstracted from each child's medical record. Descriptive statistics were used to report results.Results: From nearly 160,000 live births, 208 CCHD diagnoses were noted in the records of 157 children. Screening was noted in 67% of records of confirmed cases of CCHDs. Data completeness varied by state; for example, information was available regarding prenatal diagnosis in 91% of records and age at first surgery in 85% among states with active surveillance compared with 35% and 75%, respectively, with passive surveillance. Documentation of screening results in medical records was inconsistent. The one year survival was 85% (77/91).Conclusion: Birth defects surveillance systems can provide information on outcomes for infants with CCHDs. However, information varies by surveillance method and by hospital practices. Engaging hospitals in standardizing recording procedures and enhancing training and quality control could increase the value of birth defects registries records in assessing outcomes for children identified through CCHD screening. Birth Defects Research 109:1414–1422, 2017.


  • Public health projects for preventing the recurrence of neural tube defects in the United States

    by Julianne S. Collins, Mark A. Canfield, Kay Pearson, Russell S. Kirby, Amy P. Case, Cara T. Mai, Judy Major, Joe Mulinare

    BACKGROUND: The recurrence risk for neural tube defects (NTDs) in subsequent pregnancies is approximately 3%, or 40 times the background risk. Prevention projects target these high-risk women to increase their folic acid consumption during the periconceptional period, a behavior which decreases their recurrence risk by at least 85%. This study surveyed birth defect surveillance programs to assess their NTD recurrence prevention activities and to identify components of intervention projects that might be implemented in states with limited resources. METHODS: In 2005, the National Birth Defects Prevention Network developed and distributed an online survey to primary state birth defects surveillance contacts for the purpose of gathering information on NTD recurrence prevention activities in the United States. RESULTS: Responses came from 37 contacts in 34 states and Puerto Rico. There were 13 active NTD recurrence prevention projects, four past projects, and three planned projects. Fifteen past and present projects recommended that women with a prior NTD-affected birth take 4.0 mg of folic acid daily, and four projects provided folic acid to the women. Reasons given for not having an NTD recurrence prevention project included staffing limitations (53%), lack of funds (47%), lack of priority (18%), and confidentiality/privacy concerns (6%). CONCLUSIONS: Only 15 states and Puerto Rico had or were planning NTD recurrence prevention projects. An NTD recurrence prevention project using minimal resources should consist of timely case ascertainment, educational materials, and mechanisms for disseminating these materials. Birth Defects Research (Part A), 2009.